Villanova Investment Management Co LLC cut its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 54.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 28,040 shares of the medical instruments supplier's stock after selling 33,760 shares during the quarter. Villanova Investment Management Co LLC's holdings in DENTSPLY SIRONA were worth $419,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. bought a new position in DENTSPLY SIRONA during the first quarter worth $25,000. Brooklyn Investment Group bought a new position in DENTSPLY SIRONA during the first quarter worth $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in DENTSPLY SIRONA during the first quarter worth $26,000. Caitong International Asset Management Co. Ltd lifted its stake in DENTSPLY SIRONA by 8,003.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier's stock worth $34,000 after purchasing an additional 2,241 shares during the last quarter. Finally, Allworth Financial LP lifted its stake in DENTSPLY SIRONA by 175.8% during the first quarter. Allworth Financial LP now owns 3,949 shares of the medical instruments supplier's stock worth $54,000 after purchasing an additional 2,517 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Trading Up 0.6%
Shares of NASDAQ:XRAY traded up $0.09 during midday trading on Tuesday, reaching $13.63. The company had a trading volume of 923,754 shares, compared to its average volume of 2,974,355. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $27.48. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of -2.87, a price-to-earnings-growth ratio of 0.85 and a beta of 0.96. The company has a fifty day simple moving average of $14.69 and a two-hundred day simple moving average of $14.98.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The business had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. During the same quarter last year, the company posted $0.49 EPS. DENTSPLY SIRONA's revenue for the quarter was down 4.9% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.
DENTSPLY SIRONA Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Investors of record on Friday, September 26th will be given a $0.16 dividend. The ex-dividend date is Friday, September 26th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.7%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -13.50%.
Wall Street Analysts Forecast Growth
XRAY has been the topic of several analyst reports. Barrington Research dropped their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set an "outperform" rating on the stock in a research report on Friday, August 8th. Wall Street Zen lowered DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. UBS Group dropped their target price on DENTSPLY SIRONA from $25.00 to $24.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of DENTSPLY SIRONA in a research report on Monday, July 21st. Finally, Stifel Nicolaus dropped their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research report on Friday, August 8th. Two analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $18.64.
Check Out Our Latest Research Report on XRAY
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.